Literature DB >> 7815221

Spectrum of disease associated with anti-neutrophil cytoplasmic autoantibodies in pediatric patients.

E N Ellis1, E G Wood, P Berry.   

Abstract

Anti-neutrophil cytoplasmic autoantibodies (ANCA) are usually determined during the diagnostic evaluation of systemic vasculitis and glomerulonephritis syndromes in adult patients, but few pediatric patients with ANCA have been reported. We describe five pediatric patients with ANCA and glomerulonephritis, with and without upper or lower respiratory tract disease. We compared these five patients and six previously described patients to affected adults; the spectrum of ANCA-associated disease appears to be similar in adults and children, but a female predominance may exist in the pediatric patients. Pediatric patients often had end-stage renal disease within 1 year after onset. We conclude that ANCA is a useful diagnostic tool in both pediatric and adult patients with systemic vasculitis and glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815221     DOI: 10.1016/s0022-3476(95)70497-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

2.  The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.

Authors:  Feng Yu; Jian-Ping Huang; Wan-Zhong Zou; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

3.  Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.

Authors:  XiaoWei Li; ShaoShan Liang; ChunXia Zheng; CaiHong Zeng; HaiTao Zhang; WeiXin Hu; ZhiHong Liu
Journal:  Pediatr Nephrol       Date:  2014-07-16       Impact factor: 3.714

Review 4.  Antineutrophil cytoplasm antibodies and vasculitis.

Authors:  M C Nash; M J Dillon
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

5.  Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.

Authors:  Daishi Hirano; Tomoaki Ishikawa; Aya Inaba; Mai Sato; Tomohiro Shinozaki; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2019-05-10       Impact factor: 3.714

6.  Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis.

Authors:  Toshiyuki Ohta; Takashi Sakano; Mami Shiotsu; Takeki Furue; Hideyuki Ohtani; Yoshihisa Kinoshita; Tatsuya Mizoue; Katsuzo Kiya; Issei Tanaka
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

7.  Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.

Authors:  Anne M Kouri; Sharon P Andreoli
Journal:  Pediatr Nephrol       Date:  2016-09-27       Impact factor: 3.714

8.  Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.

Authors:  S N Wong; V Shah; M J Dillon
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

9.  Microscopic polyangiitis in an adolescent presenting as severe anemia and syncope.

Authors:  Eric J Dziuban; Valerie P Castle; Hilary M Haftel
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 3.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.